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Almost exactly two years ago, HEPP Report
published an article discussing HIV+ inmates'
constitutional rights to medical care in light of
two divergent cases recently decided at the
federal appellate court level.1 This month's
article re-examines those cases and looks at
what has happened since then to guide cor-
rectional medical providers through this murky
area of the law.
As HIV health care professionals know, every-
thing changed in 1996 with the advent of
Highly Active Antiretroviral Therapy (HAART),
and more changes are on the horizon. As
ever-changing standards for HIV treatment
enter prisons and jails, correctional medical
staff faces the unique issue of ensuring that
patient care satisfies the 8th Amendment of
the Constitution, the amendment prohibiting
"cruel and unusual punishment."  It is only nat-
ural that medical staff would want the courts to
provide clear guidance as to what kind of treat-
ment would and would not violate an inmate's
rights. But the law rarely provides such clear
and concise answers, and this is nowhere
more evident than in 8th Amendment law. 
Perhaps this is for the best. After all, courts are
not in the business of diagnosis and typically
preface 8th Amendment medical rulings with
language to this effect. This means that courts
will not second-guess a treatment decision
unless there is compelling evidence that a par-
ticular action - or inaction - was clearly inap-
propriate. Therefore, it is unlikely that the
courts will everstate, as a matter of law, that
HIV-positive inmates are entitled to a certain
type of care. Instead, courts will look to a med-
ical provider's particular state of mind, in light
of individual circumstances, to determine
whether or not he or she has violated the 8th
Amendment.
The 8th Amendment
The original intent of the 8th Amendment was
to prevent tortures and other barbarous forms
of punishment or actions that offend the "con-
science of mankind." Estelle v. Gamble, 429
U.S. 97, 102 (1976). Later, 8th Amendment
cases reflected a more idealistic vision, pro-
hibiting actions incompatible with "the evolving
standards of decency that mark the progress
of a maturing society."  Id. at 105. Under these
principles the Supreme Court interpreted the
8th Amendment to include medical treatment,
based on the fact that denying medical care
would result in unnecessary suffering that
could serve no penal purpose. 
Later cases that apply Estellehave led to an
interpretation of three basic rights for all pris-
oners: The right to access to care; the right to
a medical opinion; and the right to have that
opinion carried out. Estellealso affirmed the
seminal test the Court will use to determine
8th Amendment violations: whether correc-
tional staff has shown deliberate indifference
to an inmate's serious medical needs.
The first time the Court seriously expounded
on the test of "deliberate indifference" was in
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The courts would appear
to come to opposite 
conclusions in HIV cases.
But further analysis 
shows that it may be 
just that: an appearance.
Farmer v. Brennan, 511 U.S. 825 (1994).
In this case, the Court sought to clarify
what "deliberate indifference" really
means. Inherent to "deliberate indiffer-
ence" is that prison staff knowinglyacted
or failed to act. But it's not quite this sim-
ple. Even in this pivotal case, the Court
struggled for a definition. Circling around
the issue, the Court describes deliberate
indifference as lying "somewhere between
the poles of negligence at one end and
purpose or knowledge at the other."  Id. at
836. The Court elaborates: deliberate
indifference is something less than acts or
omissions for the very purpose of causing
harm or with knowledge that harm will
result. Id. at 835. However, it is something
more than failing to alleviate significant
risk that staff should have known about.
Id. at 838. Similarly, deliberate indiffer-
ence may be found where a risk of harm
was patently obvious (Id. at 842), but can-
not be found where an inmate plaintiff has
only proven negligence or even malprac-
tice (which do not have a state of mind
requirement). Id. at 835. 
With this as a framework, it is no surprise
then that the courts, applying the Farmer
standard, would appear to come to oppo-
site conclusions in HIV cases. But this
appearance may be just that: an appear-
ance. The apparent contrast in the follow-
ing cases, upon analysis, really points to
the direction the courts are heading in
their decisions of HIV cases in corrections
and are quite useful instructional and pre-
dictive tools. 
How the Circuit
Courts Have Addressed
HIV Treatment
Two cases at the circuit court level (just
below the Supreme Court) have dealt with
denial of HIV treatment under the 8th
Amendment. In Perkins v. Kansas
Department of Corrections, 165 F.3d 803
(1999), an HIV+ inmate was treated with
AZT and 3TC, but denied a protease
inhibitor, a critical component of proper
treatment. The 10th Circuit Court ruled for
the prison, holding that the inmate simply
disagreed with his treatment, which could
never amount to a constitutional violation.
Id. at 811.
Around the same time, in Sullivan v.
County of Pierce, 216 F.3 1084 (2000)
(Unpublished Decision)2 , the 9th Circuit
Court addressed the issue of whether
denying an inmate his HIV "cocktail" for
just two or three days could amount to an
8th Amendment violation. In this case, the
court said, it might. Id.
While these cases appear to contradict
each other, they both apply the Farmer
standard of deliberate indifference. The
legal distinction between them is solely
about the state of mind of the medical
staff. The court in Perkinswas aware of
what established treatment protocols
were, even citing medical text that affirms
the necessity of protease inhibitors. 165
F.3d at FN9. However, without evidence
that staff knowingly provided substandard
care, there can be negligence or malprac-
tice, but no constitutional violation.
By contrast, in Sullivan, there were myriad
allegations that staff knew that denying
HIV treatment for any length of time creat-
ed serious risks. Indeed, there was testi-
mony that it was "common medical knowl-
edge that an AIDS patient taking protease
inhibitors as part of an AIDS cocktail h d
to remain in strict compliance with that
regimen at all times and without excep-
tion, lest the cocktail become ineffective."
216 F.3 at 1084.
Lower Court Cases
since Perkins and
Sullivan
Since Sullivan, no other federal appellate
court has examined the issue of proper
HIV treatment under the 8th Amendment.
Lower courts, though, have dealt with HIV
treatment on numerous occasions, some-
times echoing Perkins, and sometimes
extrapolating from other non-HIV prece-
dent-setting cases - but all of them apply-
ing the rules from the Supreme Court
case of Farmer v. Brennan. In each case,
the fundamental question is "what did the
staff know?”
A typical analysis in the P rkinsvein can
be found in Evans v. Bonner, 196 F.
Supp.2d 252 (E.D.N.Y. 2002): an HIV+
i mate in New York suffered a sharp
increase in his viral load possibly due to
repeated delays and missed doses of his
medications; the court stated that these
interruptions may have amounted to neg-
ligence. But because the inmate could not
show that the nurse in charge of adminis-
tering medicines knew that her actions put
him at substantial risk of harm, his 8th
Amendment challenge failed. Using the
ame rationale, a Pennsylvania court in
Clark v. Doe, 2000 WL 1522855
(E.D.Pa.), dismissed an inmate's claim
that denial of his HIV regimen for two days
was a constitutional violation.
Other courts have read the Farmer"delib-
erate indifference" standard perhaps more
broadly. In Taylor v. Barnett, 105 F.
Supp.2d 483 (E.D.Va. 2000), an HIV+
inmates' treatment regimen was changed,
resulting in increased side effects and
decreased efficacy. The inmate alleged
that the change in treatment was motivat-
ed solely by cost considerations. 105 F.
Supp.2d at 489. The court held that such
an allegation, if true, was sufficient to
show deliberate indifference and that
treatment decisions made "solely upon
cost considerations without medical ratio-
nale" are "unacceptable." Id.
Some courts have inferred that medical
staff was deliberately indifferent simply
because the risk of harm from the alleged
action or inaction was exceedingly obvi-
ous (Davis v. Prison Health Services,
2002 WL 237871, 2 (D.Del.)), or that non-
medical rationales for treatment decisions
would almost always constitute deliberate
indifference (Cloud v. Goldberg, 2000 WL
157159, 3 (E.D.Pa.)). For example, a pat-
tern of missed dosages due to lockdowns
or transfers could amount to a constitu-
tional violation.
Ensuring an Inmate's
Rights Under the
Eighth Amendment
Because deliberate indifference is ana-
lyzed only in light of the individual circum-
stances of each case, how can medical
staff in correctional settings know where
the line is between constitutional and
unconstitutional treatment? Amidst the
ambiguities and semantic struggles within
he body of 8th Amendment law, there is
one constant upon which medical staff
can rely:  "[w]hether one puts it in terms of
duty or deliberate indifference, prison offi-
cials who act reasonably cannot be found
2
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The more inappropriate
a treatment decision is
in light of a patient's
serious need, the more
likely it is that staff
members were 
deliberately indifferent.
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Dear Correctional Colleagues:
At first glance, you may be surprised that this month's lead article has a legal, rather than a
medical, theme; however, I think you will agree that it is useful for correctional health care pro-
fessionals to understand the legal basis for inmates' constitutional right to health care. What is
a bit more difficult to grasp is exactly whether the standard of health care for prisoners is the
same as for patients on the outside. Indeed, the cases discussed indicate that the courts feel
that these standards may differ. Speaking from my experience within my own state, where I
help coordinate the care of approximately 2500 HIV-infected individuals, I believe that the stan-
dard of care is the same for all HIV-infected individuals regardless of incarceration status.
What is clear from the article is that the courts have helped to establish better health care sys-
tems for incarcerated patients. But that is only part of the story. An increased awareness of
social issues that started in the 1960s and 1970s, health care professionals choosing to work
in corrections (rather than it being a last resort for unqualified workers), and voluntary compli-
ance with standards set by the Joint Commission for the Accreditation of Health Care
Organization and other regulatory boards have all helped to elevate the standard of correc-
tional health care to its present status. We at HEPP Report also like to believe that we have
contributed to this new spirit of professionalism that characterizes the practicing correctional
HIV provider. We have done this by providing state-of-the art HIV and infectious diseases man-
agement information to our readership over the last five years. Going forward, we can all strive
to make maximal suppression of HIV viral replication the standard of care in our own institu-
tions. By doing so, we can prevent progressive immunosuppression and reconstitute our
patients' depleted immune systems. This in turn will serve to avert opportunistic infections and
malignancies, and lead to longer, healthier lives for those we serve.
Our commitment to treating HIV/AIDS patients is especially critical in light of the CDC's study
of incarceration history among people with HIV/AIDS. The finding: 48% of the 2,639 HIV/AIDS
patients questioned reported having been incarcerated at least once (see this issue's Spotlight
for more details). The study emphasizes how important it is for correctional health care
providers to encourage at-risk inmates to undergo HIV testing and provide education for all
prisoners about risk-reduction methods. 
After reading this issue, readers should be familiar with legal issues in correctional health care,
specifically as they relate to the standard of care provided to HIV+ inmates; how the courts
have ruled on previous cases; and the 8th Amendment standards by which correctional health
care providers are judged.
Sincerely yours,
David Paar, M.D.
Letter from the Editor
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4liable" under the 8th Amendment.
(Farmer, 511 U.S. 842, a standard that
incorporates due regard for prison offi-
cials' "unenviable task of keeping dan-
gerous men in safe custody under
humane conditions.") 
In practical terms, this means that
medical staff who stay reasonably
abreast of HIV treatment develop-
ments and practice in good faith can
never be deliberately indifferent, pro-
viding they afford their inmates the
benefit of their medical skill. 
Conclusion
While courts look at patients' suffering
from a variety of disease entities, HIV
is of particular interest to the judiciary
because of its high prevalence within
the correctional environment. As with
poor treatment of HIV, poorly-treated
tuberculosis or other infectious entities
would be held to similar standards.
The controversy and litigation con-
cerning HIV can be attributed to initial
resistance in some correctional set-
tings to treat the disease adequately.
Eighth Amendment rulings have con-
templated changes in medical wis-
dom. As the court noted in Sullivan,
the more inappropriate a treatment
decision is in light of a patient's seri-
ous need, the more likely it is that staff
members were deliberately indifferent.
216 F.3d at 1084. Thus, as certain
treatments become established proto-
cols, and knowledge about drug resis-
tance and HIV become commonplace
in the medical profession, correctional
medical staff will likely be increasingly
held to those standards of knowledge
by virtue of their obviousness. It is
highly unlikely, however, that courts
will ever cease to recognize the partic-
ular realities of working within the cor-
rectional environment.
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HEPPigram: Proposed Decision Tree for Initiating or
Restarting Antiretroviral Therapy
Correctional doctors face important decisions regarding starting or restarting therapy for HIV+
patients while evaluating inmates at intake. HIV+ inmates may have experienced an interrup-
tion in therapy for any number of reasons (see the lead story for more discussion on the legal
implications of this). This decision tree was developed by HEPP editors to describe a frame-
work for decisions on restarting treatment for an HIV-infected inmate who enters a facility off
medications. As always, actual decisions regarding ART are complex and involve talking with
patients to thoroughly discuss treatment options. 
Intake: inmate/patient
meets criteria for ART.
Patient currently on ART
with minimal (<7 days) disruption.
Patient not currently on ART.
Continue ART
Check viral load.
Previously on ART ART naive
Doesn’t want ART
Educate
Stopped ART for
other reasons.
Stopped ART because
although adherent, had
virologic or clinical failure.
Has been off ART
for <2 weeks.
Has been off ART
for >2 weeks.
Restarting therapy less urgent.
Review medical records.
Review adherence (poor
adherence side effects).
Restarting more urgent.
Restart same regimen
ASAP.
Prior regimen suboptimal.
Select new regimen.
modify at least two drugs.
Prior regimen
optimal. Restart.
Educate, offer therapy
if appropriate
Wants ART
Measure baseline viral load
and CD4 T-cell counts.
Stopped ART due to
significant side effects.
Select a new regimen,
adding at least two new drugs
to which expect minimal resistance.
Carefully monitor viral load and
CD4 count, looking for possible
failure. If poor response,
consider genotyping and select
a new regimen.
Rebecca Nerenberg*, HEPP Staff
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Spotlight: XIV International AIDS Conference Update: U.S. Prison News
ACCESS TO CARE
Access to care was a key theme at this year's International AIDS
Conference in Barcelona, Spain held in July 2002. Access to anti-
retroviral drugs, lab work such as CD4 counts and viral load (VL)
monitoring, and HIV-knowledgeable clinicians are key elements
of the struggle against HIV disease. Although the discussion
focused on the developing world, much of what was presented in
the session on the incarcerated echoed what has been known in
the U.S. prison community for years: prisoners have a higher
prevalence of HIV, other STDs, HCV, and drug use than the gen-
eral population. Inmates often live on the edges of society and
have less access to testing and treatment. Ultimately, presenters
agreed, incarceration can be a pivotal time and place to test and
treat a community at high risk for HIV infection.
U.S. UPDATE
According to Ted Hammett of Abt Associates group, 25% of HIV-
infected people in the U.S. cycle through prisons and jails in any
given year. This translates to 2.2% (40,000) of inmates being HIV-
infected compared with 0.3% of the total U.S. population.  The
burden of HIV among prisoners is generally higher in developed
(rather than developing) countries, especially in those countries
with high incarceration rates such as the U.S. (666/100,000).1
Another important theme of the conference that applies to correc-
tions is that prevention and treatment efforts work best when
offered together. In a study from the Project START team2,
researchers interviewed 18-29 year-old releasees about their per-
ceptions on infection, personal experiences, and strategies for
protection in regard to substance abuse and sexual activity in
prison. The sentiments from these recent releasees were that
access to drugs and alcohol were as common within corrections
as they were on the street. Releasees alleged that they were able
to access these commodities from other inmates, outside visitors,
and corrections staff, and paid for them with cash or sexual
favors. They claimed that needles for injection drug use came
from diabetics, were commonly shared, and rarely cleaned. The
interviewees estimated that more than 50% of prison inmates
were using drugs, alcohol, or both while incarcerated. 
Moreover, 15.6% of the interviewees admitted to having sex while
incarcerated. Although inmates expressed a desire to do what
they could to protect themselves against HIV and other STDs,
they were pessimistic about their ability to do so due to prison
guidelines that usually prohibit distribution of condoms.
IMPORTANCE OF HIV TESTING IN
CORRECTIONS
While much of the work on HIV in corrections focuses on the per-
centage of inmates with HIV infection, the CDC3 investigated the
issue from the opposite perspective and asked: How many peo-
ple with HIV/AIDS have ever been incarcerated? Of the 2,639
patients questioned, 48% answered that they had been incarcer-
ated at least once. Twelve percent of that group were initially diag-
nosed in a correctional facility. The proportion of HIV-infected per-
sons having ever been incarcerated are shown by sex and age in
Figures 1 and 2. 
This study emphasizes that because a large proportion of HIV-
infected people have been incarcerated at least once, it is impor-
tant that correctional physicians encourage HIV testing for at-risk
individuals and educate prisoners about risk-reduction methods. 
A study from the Harvard School of Public Health examined the
barriers to HIV testing perceived by incarcerated men in the U.S.4
The main barriers reported for testing prior to incarceration includ-
ed a lack of time, low priority, insufficient resources, low perceived
risk for HIV infection, and fear of knowing the results. According
to study participants, many of these barriers are alleviated in
prison. In most correctional facilities, testing is free, easily acces-
sible, and convenient; in some settings, testing is mandatory.
Unfortunately, while the men reported an increased use of testing
services inside correctional institutions, many alleged that they
did not receive their test results and reported insufficient pre- and
post-test counseling. The study concluded that while access to
testing in corrections is vital, the corresponding support services
must also be available. 
LESSONS LEARNED FROM THE XIV
INTERNATIONAL AIDS CONFERENCE
Many of the themes evident during the conference were applica-
ble to the challenges of HIV in prisons and jails. HEPP Advisor
Helene Gayle, MD, of the Bill & Melinda Gates Foundation,
reminded us "effective prevention is more than just education."5
This is especially true in corrections, where traditional education
may not be effective due to high illiteracy rates. Correctional
health care providers should employ a combination of approach-
es in order to reach the largest number of at-risk individuals and
must understand the resources available to the patient popula-
tion. 
Continued on page 7
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Figure 1. Percentage of HIV-infected persons 
ever incarcerated, by sex.
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Figure 2. Percentage of HIV-infected persons 
ever incarcerated, by age.
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A significant number of persons infected with HIV, tuberculosis (TB), hepatitis, syphilis, gonorrhea, and/or chlamydia are
unaware of being infected at the time of their entry to prison or jail. Screening and prevention programs differ widely among
correctional institutions, ranging from mandatory testing to testing only at the inmates' request. 
The recently released National Commission on Correctional Health (NCCHC) report to Congress on the status of soon-to-be-
released inmates found that:
w A "significant proportion" of prisons and jails do not adhere to CDC standards with regard to screening for and treating 
latent and active TB. About 10 percent of state and federal prisons and about 50 percent of jails do not have 
mandatory TB screening for inmates at intake and annually thereafter.
w Approximately 500,000 individuals latently infected with TB are released each year from jails and prisons.
w Less than one-quarter of jail inmates undergo routine laboratory testing for syphilis during incarceration.
w Approximately 500,000 individuals with sexually transmitted diseases (STDs) are released each year from jails 
and prisons.
The NCCHC report finds that due to the high prevalence of infectious diseases among the incarcerated, routine screening can
be cost saving and cost-effective in most situations. For those systems unable to implement universal screening for STDs, tar-
geted age-based and symptom screening for some STDs can be even more cost-effective.
Logistical barriers (e.g., short periods of incarceration, frequent inmate movement), lack of resources, and lack of leadership
can present formidable obstacles to providing screening (and treatment) at intake. However, model programs such as those in
Massachusetts' Hampden County Correctional Center and Virginia's Fairfax County Jail have demonstrated that through col-
laboration with public health departments and community-based organizations these barriers can be overcome.
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HIV
HCV
HBV
Syphilis
Gonorrhea and
Chlamydia
w Encourage all those with risk factors to be tested
w Provide education to all concerning decreasing the risk for transmission
w Refer HIV-infected patients for evaluation for treatment 
w Encourage all those with risk factors to be tested
w Provide education to all concerning decreasing the risk for transmission
w Provide education to all those infected concerning avoiding further liver injury i.e. alcohol avoidance
w Refer HCV-infected patients for evaluation for treatment
w Vaccinate those who are non-immune for HAV 
w Vaccinate all those who are non-immune 
w Encourage all those with risk factors to be tested
w Provide education to all concerning decreasing the risk for transmission
w Refer those who are infected for treatment 
w Encourage all those with risk factors to be tested
w Provide education to all concerning decreasing the risk for transmission
w Refer those who are infected for treatment 
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Routine Screening of Inmates at Intake
AN APPROACH TO INFECTIOUS DISEASE INTAKE SCREENING 
Paul Farmer, AIDS researcher from Harvard Medical School,
commented on the problem of HIV infection in prisons: "The
largest cities in the world will have to deal with [the problem of HIV
concentration in their] prisons and jails or these sites will continue
to seed the epidemic. First, [they must] deal with harm reduction
and then [they must deal with] access to treatment and care."6
We will "pay now or pay later," said Gayle; the longer we wait, the
more we will pay, both financially and "in human life and suffer-
ing." While "the best time to plant a tree is 20 years ago, the next
best time is now."7
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Visit: http://www.nctc2002.com/
North American AIDS Treatment
Action Forum
December 8-11, 2002
New Orleans, Louisiana 
Fee: After Nov. 8, $225
Call: Paul Woods,
202.483.6622 ext. 343
Email: pwoods@nmac.org
Visit: www.nmac.org/nataf/2002
American Correctional
Association Winter Conference
January 11-15, 2003
Charlotte, North Carolina
Call: 800.222.5646 ext. 1922
Visit: www.aca.org
Hepatitis C Management 
for Prisoners
January 25-26, 2003
San Antonio, Texas
For abstract forms and more
information, visit
http://www.med.umn.edu/cme/htm/
hepcoordinators.html
National Hepatitis Coordinators'
Conference
January 26-30, 2003
San Antonio, Texas
Fee: $125
Call: 800.776.8636
Visit: http://www.med.umn.edu/
cme/brochures2002/hepco-
ord2003/hepcoordbro2003.html
10th Conference on
Retroviruses and Opportunistic
Infections
February 10-14, 2003
Boston, Massachusetts
Call: 703.535.6862
Email: info@retroconference.org
Visit: www.retrocon-
ference.org/2003
Management of HIV/AIDS in 
the Correctional Setting 
Satellite Videoconference
Hepatitis B & C with HIV 
Co-infection: A Diagnostic 
& Treatment Update
March 11, 2003 
12:30-3:30 p.m. ET  
CME & Nursing Credits Available
E-mail: ybarraj@mail.amc.edu
Call: (518) 262-4674
Visit: www.amc.edu/Patient/
HIV/hivconf.htm
Save the 
Dates
7
HCV
FDA Approves Pegasys Monotherapy
The FDA has approved Pegasys (pegylated
interferon, Roche brand) as monotherapy for the
treatment of hepatitis C. Adults with chronic
hepatitis C who have compensated liver disease
and who have not previously been treated with
interferon alpha are approved for the drug, which
must be injected once a week. The FDA is
reviewing Roche's application for combination
therapy of Pegasys and ribavirin; approval is
expected in December. http://www.natap.org,
10/16/02
New Jersey to Pay for Testing and Treatment
of Inmates with HCV
New Jersey announced it will immediately begin
covering the costs of hepatitis C testing and
treatment for prisoners who are infected with the
virus. Under a new agreement with Correctional
Medical Services, the state will cover the cost of
testing, medications and any additional staff
needed to administer the program. Other states
with similar programs have reported spending
$15,000 to $25,000 per inmate for testing, moni-
toring, and treatment. New Jersey has identified
1,170 HCV-positive inmates. http://www.kaiser-
network.org, 11/01/02
HIV
Study: HAART Alters Mortality Patterns
As HAART was introduced and became more
widely used, AIDS-related deaths in San
Francisco declined, while mortality associated
with non-AIDS-related malignancies, chronic dis-
eases and injection drug use has not changed,
according to a recent study by Dr. Janice K.
Louie from the University of California, San
Francisco. The study analyzed deaths among
AIDS patients in San Francisco from 1994 to
1998. Reuters Health, 10/24/02
Mental Health Issues Common, But Often
Neglected in HIV Patients
While approximately four out of five patients with
HIV suffer psychiatric symptoms, only about a
third of patients reported having ever been
asked by their physicians about these symp-
toms. A supplement to the Journal of the
International Association of Physicians in AIDS
Care(IAPAC) stated that the most common self-
reported psychiatric symptoms were depression,
anxiety, insomnia, lethargy, irritability, impaired
concentration, and mood swings. Most physi-
cians in the survey (80%) attributed the psychi-
atric symptoms to antiretroviral drugs, but the
study's author pointed out that symptoms (espe-
cially from Efavirenz) tend to resolve after the
first month. Psychostimulants, antidepressants,
and tricyclics can also be used effectively in
some patients. http://www.hivandhepatitis.com,
10/28/02
Fuzeon Given Priority Review Status
The FDA has given Enfuvirtide/T-20 (Fuzeon)
priority review status. Roche and Trimeris Inc.
announced that they expect a decision by March
16, 2003. http://www.natap.org, 10/15/02
BMS Extends Price Hold
Bristol-Myers Squibb (BMS) is extending its
existing price hold on its three marketed anti-HIV
medications to state AIDS Drug Assistant
Programs (ADAPs) through March 2004. For
information on BMS's Patient Assistance
Program, call 877-758-7877.
http://www.natap.org, 10/11/02
Judge Hears Argument to End Oversight of
Georgia Jail
U.S. District Court Judge Marvin Shoob heard
arguments in a motion to end court oversight of
the Fulton County, Georgia Jail. The court's
oversight began in 1999 after HIV-inmates filed
suit over allegations they did not receive ade-
quate medical care. Shoob said that the jail has
made "substantial progress" in improving condi-
tions for HIV-positive inmates, but did not issue
an immediate decision on the motion.
Atlanta Journal-Constitution, 10/18/02
S uth African Prisons 'Breeding Ground' for
HIV/AIDS
Crowded South African prisons have become a
"breeding ground" for HIV/AIDS, according to the
AP/Seattle Post-Intelligencer. HIV/AIDS is
believed to be largely responsible for the 500%
increase in prison deaths between 1995 and
2001, reported a judge who oversees the coun-
try's prison conditions. About 41% of the nation's
inmates are believed to be HIV-positive.
AP/Seattle Post-Intelligencer, 10/21/02
Inside News
Resources & Websites
HEPP Report
Includes archives of all issues 
http://www.hivcorrections.org
HIV and Its Treatment: What You Should
Know, September 2002
http://hivatis.org/publications/hivtr.pdf
National Institute on Drug Abuse 
New Requests for Applications
http://www.nida.nih.gov/Funding/rfplist.html
Lipo2002 Abstracts
Abstracts from the 4th International Workshop on
Adverse Drug Reactions and Lipodystrophy in
HIV, (September 22-25 in San Diego) are now
available for download.
http://www.intmedpress.com
National Institute on Drug Abuse - 
New Requests for Applications
http://www.nida.nih.gov/Funding/rfplist.html
National HCV in Prison Coalition
http://www.hcvinprison.org/
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Self-Assessment Test for Continuing Medical Education Credit
Brown Medical School designates this educational activity for 1 hour in category 1 credit toward the AMA Physician’s Recognition Award.
To be eligible for CME credit, answer the questions below by circling the letter next to the correct answer to each of the questions. 
A minimum of 70% of the questions must be answered correctly. This activity is eligible for CME credit through May 31, 2003. 
The estimated time for completion of this activity is one hour and there is no fee for participation.
1. When applying the eighth amendment to the evaluation of care
given to prisoners, courts look to: 
(a)  Proof of deliberate indifference
(b)  Whether the action was medically appropriate
(c)  Whether the correct level of care was given
(d)  Whether the treatment met the latest medical standards
2. The Eighth Amendment specifically:
(a)  States that all inmates have the right to medical care
(b)  Prohibits cruel and unusual punishment
(c)  States that inmates have the right to litigate if they are 
not satisfied with their level of care
(d)  None of the above
3. Estelle v. Gamble(1976) has led to a widely-held interpretation
that inmates have: 
(a)  The right to access to care
(b)  The right to a medical opinion
(c)  The right to have a medical opinion carried out
(d)  All of the above
4. In Perkins v. KansasDepartment of Corrections, the 10th
Circuit Court ruled that denying an HIV+ inmate his protease
inhibitor was unconstitutional.
(a)  True
(b)  False
5. The Courts are clear about the level and type of treatment that
should be given to HIV+ prisoners, and generally rule accordingly
in favor of inmates who have not received the medically accepted
standard of care:
(a)  True
(b)  False 
6. In Farmer v. Brennan, the Court clarified "deliberate 
indifference" as:
(a)  When prison staff knowingly acted or failed to act
(b)  Medical malpractice
(c)  Negligence
(d)  None of the above
BROWN MEDICAL SCHOOL •  OFFICE OF CONTINUING MEDICAL EDUCATION •  BOX G-A2  •  PROVIDENCE, RI 02912
The Brown Medical School is accredited by the Accreditation Council for Continuing Medical Education (ACCME)to provide continuing medical 
education activities for physicians.  
The use of the Brown Medical School name implies review of the educational format and material only.  The opinions, recommendations 
and editorial positions expressed by those whose input is included in this bulletin are their own.  They do not represent or speak for the 
Brown Medical School.
For Continuing Medical Education credit please complete the following and mail or fax to 401.863.2660 or 
register online at www.hivcorrections.org. Be sure to print clearly so that we have the correct information for you.
Name __________________________________________________________________ Degree ____________________
Address ____________________________________________________________________________________________
____________________________________________________________________________________________________
City ____________________________________________________ State ________ Zip ________________________
Telephone ________________________________________________ Fax ______________________________________
HEPP Report Evaluation
5 Excellent    4 Very Good    3 Fair    2 Poor    1 Very Poor
1. Please evaluate the following sections with respect to:
educational value clarity
Main Article 5  4  3  2  1   5  4  3  2  1     
HIV 101 5  4  3  2  1   5  4  3  2  1  
Inside News 5  4  3  2  1   5  4  3  2  1
Save the 
Dates 5  4  3  2  1   5  4  3  2  1
2. Do you feel that HEPP Report helps you in your work?
Why or why not?
3. What future topics should HEPP Report address?
4. How can HEPPReport be made more useful to you?
5. Do you have specific comments on this issue?
8November 2002     Volume 5, Issue 11visit HEPP Report online at www.hivcorrections.org
